Canine myxomatous mitral valve disease (MMVD) is similar to Barlow's form of MMVD in
humans. These valvulopathies are complex, with varying speeds of progression. We …

Valvular heart disease accounts for over 20 000 deaths and 90 000 hospitalizations yearly
in the United States. Myxomatous valve disease (MVD) is the most common disease of the …

Background Although it is well known that myxomatous mitral valve disease stage B2
(MMVD stage B2) is predominantly characterized by ECM remodeling of the mitral valve …

Myxomatous mitral valve disease is the single most important mitral valve disease in both
dogs and humans. In the case of the dog it is ubiquitous, such that all aged dogs will have …

Simple Summary Canine MMVD is a progressive chronic disease with variable clinical
signs, with some patients remaining completely asymptomatic while others develop CHF …

Myxomatous mitral valve disease (MMVD) is the most common cardiovascular disorder in
dogs with a high prevalence, accounting for approximately 75% of all canine heart disease …

Myxomatous mitral valve disease (MMVD) is the most common acquired canine
cardiovascular disease and shares many similarities with human mitral valvulopathies …

Background Pulmonary hypertension (PH) is a common complication in dogs with
myxomatous mitral valve disease (MMVD), characterized by elevated blood pressure in …

Background Myxomatous mitral valve disease (MVD) is the most common acquired heart
disease in dogs, and the Cavalier King Charles Spaniel (CKCS) is the most studied breed …

Chronic valve disease (CVD) is the most common clinically significant heart disease of dogs,
affecting 20 to 40% of dogs. The aim of this study was to evaluate the serum protein profile of …